Diseases, Conditions, Syndromes

Promising new leprosy vaccine moves into human trials

Today marks a significant step forward in the prevention and treatment of leprosy as the Infectious Disease Research Institute (IDRI) and American Leprosy Missions announce the start of a Phase 1 clinical trial in humans ...

Diseases, Conditions, Syndromes

Scientists develop improved, potentially safer Zika vaccine

The worldwide Zika threat first emerged in 2015, infecting millions as it swept across the Americas. It struck great fear in pregnant women, as babies born with severe brain birth defects quickly overburdened hospitals and ...

HIV & AIDS

Candidate AIDS vaccine passes early test

The three-decade-old quest for an AIDS vaccine received a shot of hope Monday when developers announced that a prototype triggered the immune system in an early phase of human trials.

Diseases, Conditions, Syndromes

Zika vaccine research—guidance for including pregnant women

New guidance for including pregnant woman and their babies in Zika vaccine research has been published today. It has been issued by a group of international experts in vaccinology, maternal and child health, public health ...

HIV & AIDS

Team tests best delivery mode for potential HIV vaccine

For decades, HIV has successfully evaded all efforts to create an effective vaccine but researchers at The Scripps Research Institute (TSRI) and the La Jolla Institute for Allergy and Immunology (LJI) are steadily inching ...

Medical research

Anti-heroin vaccine found effective in non-human primates

A vaccine developed at The Scripps Research Institute (TSRI) to block the "high" of heroin has proven effective in non-human primates. This is the first vaccine against an opioid to pass this stage of preclinical testing.

Diseases, Conditions, Syndromes

Chikungunya vaccine trial underway

The National Institutes of Health-funded Vaccine and Treatment Evaluation Unit at Baylor College of Medicine will be one of the sites for a clinical trial testing the safety and immune responses to a vaccine against chikungunya ...

Diseases, Conditions, Syndromes

NIAID-sponsored trial of experimental Chikungunya vaccine begins

A clinical trial of an experimental vaccine to prevent infection with chikungunya virus is now enrolling healthy adult volunteers at sites in the United States. The Phase 1/2 trial, which is sponsored by the National Institute ...

Diseases, Conditions, Syndromes

Development of a novel vaccine for Zika

Research presented by Farshad Guirakhoo, Ph.D., Chief Scientific Officer, GeoVax, Inc., at the ASM Microbe 2017 meeting showed a new Zika virus vaccine that gives 100% protection in mice. The vaccine is the first to be based ...

page 28 from 40